This website is in the process of being updated. Our full portfolio of products will be available on this page in due course. In the meantime, for safety and patient information relating to products not currently listed, please refer to the electronic Medicines Compendium website.
Showing refined by:
Ambirix – product, safety and patient information to support UK patients and carers when prescribed.
This page provides Anoro▼ Ellipta (umeclidinium/vilanterol) product overview and what it is used for, chronic obstructive pulmonary disease (COPD)
Avamys (fluticasone furoate) links to the summary of product characteristics and patient information leaflet for UK members of the public.
Bexsero▼ (Meningococcal group B Vaccine (rDNA, component, adsorbed)) information for members of the UK public
A product overview of the Ellipta device for members of the UK public
Fluarix Tetra▼ (influenza vaccine – split virion, inactivated) - product information for members of the UK public
Havrix Monodose and Havrix Junior Monodose (Hepatitis A (inactivated) vaccine (adsorbed)) - product overview, safety and patient information for members of the UK public
Incruse▼ (umeclidinium) product information, news and links to support UK patients and carers when prescribed
Links to the summary of product characteristics and patient information leaflet for patients who have been prescribed Menveo.
The official Relvar (fluticasone furoate/vilanterol) product overview for UK members of the public.
Seretide product information and links to support UK patients who have been prescribed Seretide, and their carers.
Toctino (alitretinoin) link to summary of product characteristics, patient information leaflet, information and links to useful websites on chronic hand eczema for members of the UK public
Trelegy▼ Ellipta (fluticasone furoate/umeclidinium/vilanterol) product information for the UK members of the public
Twinrix - Hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed) - product overview, patient and safety information.
Varilrix (varicella/chickenpox vaccine) - links to the summary of product characteristics, patient information leaflet and European Public Assessment Report to support UK members of the public.
There are no results matching your refine settings
Content is provided on this website for products with a United Kingdom product licence. In some cases, content may be provided relating to products that have mutual recognition or national licence, which has been created for United Kingdom audiences.
Reporting of side effects. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.
Additional note for medicines / vaccines with a black triangle:
▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See information in paragraph above to see how to report side effects.’
M.C. Last updated: May 2018.